MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a significant drop in short interest in February. As of February 13th, there was short interest totaling 71,786 shares, a drop of 56.9% from the January 29th total of 166,605 shares. Based on an average daily trading volume, of 227,635 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 227,635 shares, the short-interest ratio is currently 0.3 days.
MediPharm Labs Trading Down 0.9%
Shares of OTCMKTS:MEDIF traded down $0.00 on Friday, hitting $0.05. 91,745 shares of the company’s stock were exchanged, compared to its average volume of 73,622. The firm’s 50-day moving average is $0.05 and its 200 day moving average is $0.05. MediPharm Labs has a 1-year low of $0.04 and a 1-year high of $0.09.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- 3 Signs You May Want to Switch Financial Advisors
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Elon Musk already made me a “wealthy man”
- The Biggest IPO Ever… Open to Everyday Folks
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
